Home / 2021 / March (Page 10)

Bharat Biotech, a global leader in vaccine innovation, developing vaccines for infectious diseases, on Friday announced the first interim analysis of its BBV152 (COVAXIN®). The whole virion inactivated COVID-19 vaccine candidate demonstrated an interim vaccine efficacy of 81% in its Phase 3 clinical trial. The

READ MORE
Newsletter Popup
MedgateToday

Every major healthcare update,
delivered to your inbox

Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.

🔒 No spam. Unsubscribe anytime.